fillpattern
Pattern fills for ggplot2, hardened against the ways users write sizes
A side-by-side editorial comparison of bayestools and medsim — release velocity, themes, recent moves, and the top alternatives to consider.
The JAGS toolkit under RoBMA, shipping the standardization machinery its downstream rewrite needed
BayesTools provides the shared JAGS fitting, prior and summary infrastructure that the author's meta-analysis packages build on. The 0.2.x line filled in modeling primitives — prior_mixture() and mixed-posterior objects in 0.2.18, expression-valued priors and lme4-style uncorrelated random effects in 0.2.20, then a run of small diagnostic fixes for mixture and spike-and-slab priors. Version 0.3.0 in May 2026 adds automatic standardization of continuous predictors, default priors for unspecified factor and continuous terms, and functions to transform prior and posterior samples back to the original scale.
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
BayesTools provides the shared JAGS fitting, prior and summary infrastructure that the author's meta-analysis packages build on. The 0.2.x line filled in modeling primitives — prior_mixture() and mixed-posterior objects in 0.2.18, expression-valued priors and lme4-style uncorrelated random effects in 0.2.20, then a run of small diagnostic fixes for mixture and spike-and-slab priors. Version 0.3.0 in May 2026 adds automatic standardization of continuous predictors, default priors for unspecified factor and continuous terms, and functions to transform prior and posterior samples back to the original scale.
This package's releases are best read against what depends on them. The 0.2.x fixes track features appearing in RoBMA one version later, and 0.3.0 landed a single day before RoBMA 4.0.0 — the standardization and sample-transformation functions are the substrate that rewrite needed. The direction of the work is toward sensible defaults: default priors by predictor type, automatic standardization for sampling stability, and transformation back to interpretable scale so the convenience does not cost the user their units.
Given how tightly its releases track downstream needs, the next version is most likely driven by gaps surfacing in RoBMA 4.0.x rather than by independent feature work.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either bayestools or medsim.
Pattern fills for ggplot2, hardened against the ways users write sizes
gcube's recent releases are all packaging metadata, not simulation code
The R port of Quinlan's Cubist gets reproducibility fixes, not new modelling
ggstats keeps widening what a coefficient or Likert plot can be
ecodive rebuilt itself into a broad diversity-metric library, breaking as it went
State-space data simulation for R, filled in one function at a time
See all bayestools alternatives → · See all medsim alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top bayestools alternatives in Analytics are ranked by recent ship velocity. Browse the "bayestools alternatives" section above for the current picks, or visit /alternatives/bayestools for the full list with editorial commentary on each.
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.